New targeted rheumatoid arthritis drug delays disease, reduces flare-ups

Medical Tech

Published on:

Source: New Atlas | New TechBy: Paul McClureDate: 08/06/2025, 5:00:00 AM
A new nanoparticle drug has shown preclinical promise in both preventing rheumatoid arthritis and reducing painful flare-ups, offering hope for a targeted, steroid-sparing treatment that calms the immune system without widespread suppression. Disease-modifying anti-rheumatic drugs, or DMARDs, have advanced the…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.
SubscribeSign in